GRDN
Guardian Pharmacy Services, Inc.
NYSE · Healthcare · Medical - Distribution · US
$44.99
−0.13%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+7.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| May 7, 2026 | COSLER STEVEN D · director | A-Award | 4,028 | $0.00 |
| May 7, 2026 | LEWIS RANDALL J · director | A-Award | 4,028 | $0.00 |
| May 7, 2026 | Patchett Mary Sue · director | A-Award | 4,028 | $0.00 |
| Mar 31, 2026 | Pharmacy Investors, LLC · other: Member of 10% owner group | M-Exempt | 1,413,939 | $0.00 |
| Mar 31, 2026 | Cardinal Equity Fund, L.P. · other: Member of 10% owner group | M-Exempt | 471,057 | $0.00 |
| Mar 31, 2026 | Forbes Kendall · officer: See Remarks | M-Exempt | 608,570 | $0.00 |
| Mar 31, 2026 | BINDLEY WILLIAM E · director, 10 percent owner: | M-Exempt | 6,100,175 | $0.00 |
| Mar 31, 2026 | Burke Fred · director, officer: See Remarks | M-Exempt | 1,298,826 | $0.00 |
| Mar 31, 2026 | Salentine Thomas J Jr · director, 10 percent owner: | M-Exempt | 6,100,175 | $0.00 |
| Mar 31, 2026 | Ackerman John · director | M-Exempt | 471,057 | $0.00 |
| Mar 31, 2026 | Ackerman John · director | M-Exempt | 1,413,939 | $0.00 |
| Mar 31, 2026 | Bindley Capital Partners I, LLC · 10 percent owner | M-Exempt | 6,100,175 | $0.00 |
| Mar 31, 2026 | Morris David K · director, officer: See Remarks | M-Exempt | 641,869 | $0.00 |
| Mar 24, 2026 | Morris David K · director, officer: See Remarks | Sale | 187,855 | $30 |
| Mar 24, 2026 | Cardinal Equity Fund, L.P. · other: Member of 10% owner group | Sale | 275,728 | $30 |
| Mar 24, 2026 | Forbes Kendall · officer: See Remarks | Sale | 346,672 | $30 |
| Mar 24, 2026 | Burke Fred · director, officer: See Remarks | Sale | 671,432 | $30 |
| Mar 24, 2026 | Pharmacy Investors, LLC · other: Member of 10% owner group | Sale | 827,636 | $30 |
| Mar 24, 2026 | Ackerman John · director | Sale | 827,636 | $30 |
| Mar 24, 2026 | Ackerman John · director | Sale | 275,728 | $30 |
| Mar 24, 2026 | BINDLEY WILLIAM E · director, 10 percent owner: | Sale | 3,570,677 | $30 |
| Mar 24, 2026 | Bindley Capital Partners I, LLC · 10 percent owner | Sale | 3,570,677 | $30 |
| Mar 24, 2026 | Salentine Thomas J Jr · director, 10 percent owner: | Sale | 3,570,677 | $30 |
| Feb 13, 2026 | Morris David K · director, officer: See Remarks | A-Award | 50,000 | $35 |
| Feb 13, 2026 | Burke Fred · director, officer: See Remarks | A-Award | 75,000 | $35 |
| Feb 13, 2026 | Forbes Kendall · officer: See Remarks | A-Award | 50,000 | $35 |
| Dec 5, 2025 | COSLER STEVEN D · director | Purchase | 3,370 | $30 |
| Sep 30, 2025 | Pharmacy Investors, LLC · other: Member of 10% owner group | Sale | 150,998 | $20 |
| Sep 30, 2025 | Ackerman John · director | M-Exempt | 1,413,940 | $0.00 |
| Sep 30, 2025 | Ackerman John · director | M-Exempt | 471,057 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 94Increased 128Reduced 97Sold out 15
| Filer | Action | Shares | Filed |
|---|---|---|---|
| FMR LLC | Increased | 3,241,612 | Aug 13, 2026 |
| FMR LLC | Increased | 2,359,357 | May 15, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Increased | 1,765,119 | May 15, 2026 |
| BLACKROCK, INC. | Increased | 1,756,374 | May 13, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Reduced | 1,729,032 | Aug 14, 2026 |
| BlackRock, Inc. | Reduced | 1,575,989 | Aug 7, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 1,379,750 | Aug 13, 2026 |
| Woodline Partners LP | Increased | 1,306,340 | Aug 14, 2026 |
| WOODLINE PARTNERS LP | Increased | 1,306,318 | May 15, 2026 |
| BROWN ADVISORY INC | Reduced | 1,259,174 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1,225,543 | May 15, 2026 |
| VALIANT CAPITAL MANAGEMENT, L.P. | Reduced | 1,186,658 | May 15, 2026 |
| Valiant Capital Management, L.P. | Unchanged | 1,186,658 | Aug 14, 2026 |
| T. Rowe Price Investment Management, Inc. | Increased | 1,116,868 | Aug 14, 2026 |
| TIMESSQUARE CAPITAL MANAGEMENT, LLC | Increased | 1,077,474 | May 7, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing May 7, 2026